- Each tablet contains: Ambroxol HCI 30 mg.
- Ambroxol has been shown to increase respiratory tract secretion. It enhances pulmonary surfactant production and stimulates ciliary activity. The result in improved mucus flow and transport (mucociliary clearance). Improvement of mucociliary clearance has been shown in clinical pharmacological studies. Enhancement of fluid secretion and mucociliary clearance facilitates expectoration and eases cough.
Secretolytic therapy in bronchopulmonary disease associated with abnormal mucus secretion and impaired mucus transport.
The tablet should be taken after meals with water.
Adult: Oral, 1-2 Tablet(s) twice daily.
Ambroxol should not be used in patients known to be hypersensitive to the active ingredient.
- Administration of Ambroxol together with antibiotics (Amoxycillin, Cefuroxime, Erythromycin, Doxycycline) leads to higher antibiotic concentration in the lung tissue.
- Keep this and all medicines out of reach of children. Store below 30°C.